全文获取类型
| 收费全文 | 49425篇 |
| 免费 | 4549篇 |
| 国内免费 | 87篇 |
专业分类
| 耳鼻咽喉 | 513篇 |
| 儿科学 | 1649篇 |
| 妇产科学 | 1201篇 |
| 基础医学 | 6456篇 |
| 口腔科学 | 776篇 |
| 临床医学 | 7179篇 |
| 内科学 | 8594篇 |
| 皮肤病学 | 556篇 |
| 神经病学 | 5049篇 |
| 特种医学 | 1207篇 |
| 外科学 | 6108篇 |
| 综合类 | 1030篇 |
| 一般理论 | 54篇 |
| 预防医学 | 6449篇 |
| 眼科学 | 735篇 |
| 药学 | 2981篇 |
| 中国医学 | 31篇 |
| 肿瘤学 | 3493篇 |
出版年
| 2022年 | 345篇 |
| 2021年 | 814篇 |
| 2020年 | 502篇 |
| 2019年 | 860篇 |
| 2018年 | 978篇 |
| 2017年 | 711篇 |
| 2016年 | 747篇 |
| 2015年 | 861篇 |
| 2014年 | 1205篇 |
| 2013年 | 2033篇 |
| 2012年 | 2863篇 |
| 2011年 | 2830篇 |
| 2010年 | 1533篇 |
| 2009年 | 1474篇 |
| 2008年 | 2721篇 |
| 2007年 | 2868篇 |
| 2006年 | 2700篇 |
| 2005年 | 2597篇 |
| 2004年 | 2624篇 |
| 2003年 | 2403篇 |
| 2002年 | 2267篇 |
| 2001年 | 1061篇 |
| 2000年 | 1060篇 |
| 1999年 | 930篇 |
| 1998年 | 654篇 |
| 1997年 | 528篇 |
| 1996年 | 522篇 |
| 1995年 | 479篇 |
| 1994年 | 438篇 |
| 1993年 | 453篇 |
| 1992年 | 754篇 |
| 1991年 | 709篇 |
| 1990年 | 708篇 |
| 1989年 | 680篇 |
| 1988年 | 670篇 |
| 1987年 | 658篇 |
| 1986年 | 601篇 |
| 1985年 | 613篇 |
| 1984年 | 507篇 |
| 1983年 | 439篇 |
| 1982年 | 402篇 |
| 1981年 | 331篇 |
| 1980年 | 334篇 |
| 1979年 | 427篇 |
| 1978年 | 280篇 |
| 1977年 | 261篇 |
| 1976年 | 297篇 |
| 1975年 | 251篇 |
| 1974年 | 313篇 |
| 1973年 | 317篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
2.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
3.
4.
5.
6.
7.
Margaret H. Lauerman Karen Irizarry Clint Sliker Brandon R. Bruns Ronald Tesoriero Thomas M. Scalea Deborah M. Stein 《Injury》2019,50(1):131-136
Background
Current blunt cerebrovascular injury (BCVI) grading grossly differentiates injury characteristics such as luminal stenosis (LS) and aneurysmal disease. The effect of increasing degree of LS beyond the current BCVI grading scale on stroke formation is unknown.Study Design
BCVI over a 3-year period were retrospectively reviewed. To investigate influence of LS beyond the BCVI grading scale within aneurysmal and non-aneurysmal BCVI, grade 2 BCVI were subdivided into BCVI with ≥ 25% and ≤ 50% LS and BCVI with > 50% and ≤ 99% LS. Grade 3 BCVI were subdivided into BCVI with pseudoaneurysm (PSA) without LS and BCVI with PSA and LS. We hypothesized increased LS beyond the current BCVI grade distinctions would be associated with higher rates of stroke formation.Results
312 BCVI were included, of which 140 were carotid BCVI and 172 vertebral BCVI. Sixteen carotid BCVI underwent endovascular intervention (EI) and 19 suffered a stroke. In carotid BCVI stroke rates increased sequentially with BCVI grade except in grade 3. There was a stroke rate of 12% in grade 1 carotid BCVI, 18% in grade 2, 6% in grade 3, and 31% in grade 4. In subgroup analysis for grade 2 carotid BCVI, BCVI with > 50% and ≤ 99% LS had higher rates of stroke (22% vs. 15%, p?=?0.44) than BCVI with ≥ 25% and ≤ 50% LS. In subgroup analysis of grade 3 carotid BCVI, BCVI with PSA and LS had higher rates of stroke (9% vs. 4%, p?=?0.48) than BCVI with PSA without LS. Higher rates of EI in grade 2 carotid BCVI with > 50% and ≤ 99% LS (22% vs. 5%, p?=?0.14) and grade 3 carotid BCVI with PSA and LS (35% vs. 4%, p?=?0.01) were noted in subgroup analysis.Conclusion
Higher percentage LS beyond the currently used BCVI grading scale has a non-significantly increased rate of stroke in both aneurysmal and non-aneurysmal BCVI. Grade 3 BCVI with PSA and LS seems to be a high-risk subgroup. Use of EI confounds modern measurement of stroke risk in higher LS BCVI. 相似文献8.
9.
10.
